Health Care & Life Sciences » Biotechnology | PTC Therapeutics Inc.

PTC Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
142,467.50
315,241.00
338,925.00
231,666.00
191,246.00
228
Total Accounts Receivable
957.70
4,445.00
11,094.00
24,929.00
40,394.00
68
Inventories
-
-
-
-
10,754.00
16
Other Current Assets
1,599.20
3,885.00
5,930.00
4,691.00
6,669.00
9
Total Current Assets
145,024.40
323,571.00
355,949.00
261,286.00
249,063.00
321
Net Property, Plant & Equipment
6,729.40
9,159.00
8,974.00
7,429.00
8,376.00
13
Intangible Assets
-
-
-
-
132,993.00
783
Other Assets
149.00
489.00
358.00
630.00
1,221.00
2
Total Assets
151,902.80
333,219.00
365,281.00
269,345.00
391,653.00
1,119
ST Debt & Current Portion LT Debt
48.60
-
-
-
-
Accounts Payable
1,123.90
4,128.00
5,779.00
6,298.00
15,282.00
Other Current Liabilities
11,960.90
28,347.00
39,607.00
43,326.00
66,766.00
Total Current Liabilities
13,133.40
32,475.00
45,386.00
49,624.00
82,048.00
Long-Term Debt
-
-
91,848.00
98,216.00
144,971.00
Other Liabilities
2,227.00
2,277.00
2,046.00
1,922.00
8,197.00
Total Liabilities
15,360.40
34,752.00
139,280.00
149,762.00
235,216.00
Common Equity (Total)
136,542.40
298,467.00
226,001.00
119,583.00
156,437.00
Total Shareholders' Equity
136,542.40
298,467.00
226,001.00
119,583.00
156,437.00
Total Equity
136,542.40
298,467.00
226,001.00
119,583.00
156,437.00
Liabilities & Shareholders' Equity
151,902.80
333,219.00
365,281.00
269,345.00
391,653.00

About PTC Therapeutics

View Profile
Address
100 Corporate Court
South Plainfield New Jersey 07080
United States
Employees -
Website http://www.ptcbio.com
Updated 07/08/2019
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders.